If you have any questions regarding the correct use of our products or need additional information, please do not hesitate to contact us
Urandur, S
Tirzepatide (Mounjaro/Zepbound): The Dual GLP-1/GIP Agonist Tirzepatide is a newer GLP-1 medication that also activates the GIP receptor, and its trial data shows somewhat greater average weight loss than semaglutide's at comparable trial lengths
These can include large swelling, redness, tissue necrosis, abscess formation, ulceration, severe pain, or allergic reactions
Diabetes education Access to experienced and caring patient educators, plus diabetes management classes, patient handouts and web resources Eating healthy support Registered dieticians who teach patients how to identify and make healthy food choices Through our holistic approach, we help patients navigate the complexities of GLP-1 therapy, ensuring they achieve the best possible outcomes while minimizing potential side effects